BCL2L11 and B-cell non-Hodgkin lymphoma: MiR 17-92 cluster is amplified in high-grade B-cell lymphoma with Burkitt lymphoma signature, resulting in higher expression of miR17-92 and lower expression of BIM and PTEN and increased BCR signaling [38].